The adeno-associated virus (AAV) Rep protein is required for both viral DNA replication and transactivation of the AAV promoters. Here we report the effects of mutations in the rep gene on transcription and replication in vivo and terminal repeat binding and terminal resolution site (trs) endonuclease activities in vitro. In all, we examined 10 in-frame deletions and 14 amino acid substitution mutations at eight positions. The point mutations were targeted to regions that are highly conserved among the parvovirus nonstructural proteins and include the extended ATPase domain of the AAV Rep protein. The mutations identify at least two noncontiguous regions of Rep which are essential for terminal repeat binding (amino acids 134 to 242 and amino acids 415 to 490). Mutations in either region render the protein inactive for both DNA replication and transactivation. In addition, mutations within a putative ATPase region also cause defects in replication and transactivation in vivo as well as in the ATP-dependent trs endonuclease activity in vitro. These results suggest that Rep transactivates via a novel mechanism which may require both DNA binding and an enzymatic activity, namely, ATPase or DNA helicase activity. The Rep protein of AAV is analogous to the nonstructural (NS) proteins of the autonomous parvoviruses and is highly conserved throughout the parvovirus group (2, 9). The fundamental roles of the Rep and NS proteins are also conserved. NS-1 has been shown to bind to the terminal palindrome of bovine parvovirus, which is similar in structure to the AAV TR (35). In the case of the parvovirus minute virus of mice, a covalent attachment to the 5' end of the viral DNA has been observed in vivo (10, 11) . Also like Rep, NS-1 protein specifically transactivates parvovirus promoters (13, 14, 37) .
Adeno-associated virus (AAV), a member of the parvovirus group, relies on coinfection with a helper virus, usually adenovirus, for the initiation of its lytic phase. The rep gene of AAV encodes four overlapping multifunctional proteins (33, 46) . These are the only AAV gene products required in trans for DNA replication (20) and for transactivation of the three AAV promoters (28, 47) located at map units 5, 19 , and 40 (p5, p19, and p40, respectively) (15, 16, 29, 31) . The role of the two larger Rep proteins, Rep68 and Rep78, during DNA replication has been characterized in some detail. Both peptides bind specifically to the AAV palindromic terminal repeats (TRs) (1, 23, 25) , which function as the origins of viral DNA replication (18, 41) . In a series of steps called terminal resolution, Rep catalyzes the endonucleolytic cleavage of the terminal resolution site (trs) within the TR, generating a primer for the initiation of a new round of viral DNA synthesis (23, 25, 44, 45) .
Both the TR-specific DNA-binding activity and the trs endonuclease activity have been demonstrated in vitro by using Rep proteins purified from infected HeLa cells (24, 25) . A requirement for ATP hydrolysis (or another nucleoside triphosphate) and concomitant covalent attachment of the Rep protein to the newly generated 5' end have also been observed during trs cleavage in vitro (25, 44) . A mutation within the putative ATP-binding domain of the Rep protein causes defective DNA replication in vivo (8) . In addition, the purified Rep68 and Rep78 proteins have an associated ATPdependent DNA helicase activity (24, 25) .
The Rep protein has pleiotropic effects on gene expression from AAV promoters, behaving as a repressor in the absence of helper virus and as a transcriptional activator when helper virus is present (4, 28, 32, 46) . Rep-mediated transactivation exhibits complex requirements for cis-acting elements. In the absence of the TRs, transactivation of the p40 promoter by Rep requires cis elements associated with the * Corresponding author. two upstream promoters, p5 and p19, in addition to multiple promoter-associated sequences within 93 bp upstream of the p40 cap site (32) . In contrast, when the TRs are present in cis, Rep activates the p40 promoter to wild-type levels in the absence of the upstream promoters (32) .
The Rep protein of AAV is analogous to the nonstructural (NS) proteins of the autonomous parvoviruses and is highly conserved throughout the parvovirus group (2, 9) . The fundamental roles of the Rep and NS proteins are also conserved. NS-1 has been shown to bind to the terminal palindrome of bovine parvovirus, which is similar in structure to the AAV TR (35) . In the case of the parvovirus minute virus of mice, a covalent attachment to the 5' end of the viral DNA has been observed in vivo (10, 11) . Also like Rep, NS-1 protein specifically transactivates parvovirus promoters (13, 14, 37) .
The Rep amino acid sequence contains no striking resemblances either to transcriptional regulator DNA-binding domains, such as the helix-turn-helix, leucine zipper, and zinc finger motifs (26) , or to previously noted transactivation domains, including acidic, glutamine-rich, and proline-rich regions (12, 22, 34) . In this study, we have used oligonucleotide-directed mutagenesis to investigate the possibility that the seemingly disparate functions of replication and transactivation are associated with discrete domains within the protein. Because Rep and NS proteins have similar roles and substantial sequence homology, we have directed point mutations toward amino acid residues which are conserved among the parvoviruses. We have assessed the effects of these mutations on transactivation and replication in transfected cells and on TR binding and trs cleavage in vitro. Our analysis has identified at least two regions of the Rep protein that are required for DNA binding. In addition, the results suggest that some of the enzymatic activities of the Rep protein that are required for DNA replication, namcly, the ATPase and DNA helicase activities, may also be required for transactivation.
MATERIALS AND METHODS
Cells and transfections. For DNA transfections, HeLa cell monolayers were grown to 50 to 75% confluence in 100-mm dishes containing 10 ml of minimal essential medium with 10% fetal bovine serum. The cells were washed with phosphate-buffered saline and transfected with 1 ml of medium containing 1 mg of DEAE-dextran per ml, 40 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 7.4), and 5 pg of Rep protein-expressing plasmid. When complementation for replication was assayed, 1 ,ug of plasmid d13-23 was cotransfected as an AAV Ori+ Rep-replicating DNA (20) . After 20 to 30 min at room temperature, the DEAE transfection mixture was removed, and the cells were washed again with phosphate-buffered saline and incubated in 10 ml of medium containing 2% fetal bovine serum and, for adenovirus type 2 (Ad2)-infected cells, Ad2 at 5 PFU per cell.
RNA isolation and analysis. At approximately 40 h posttransfection, the cells were scraped into the medium and transferred to 15-ml centrifuge tubes. Ten percent of the cell suspension was removed for analysis of low-molecularweight DNA by the Hirt extraction procedure (21) . The remaining cells were harvested by centrifugation, and the cell pellets were resuspended in 3.5 ml of 4 M guanidinium thiocyanate lysis solution (3). High-molecular-weight DNA was sheared by sonication. The lysate was layered over 5.7 M CsCl, and the RNA was separated by centrifugation at 150,000 x g.
For primer extension assays, 10 to 20% of an ethanol suspension of the RNA from a 100-mm dish was mixed with 5'-end-labeled, gel-purified primer and centrifuged. The pellet was dissolved in 20 p.l of 34 mM Tris-HCI (pH 8.3)-6 mM MgCl2-50 mM NaCl-5 mM dithiothreitol and allowed to anneal for 1 h at 65°C. The annealed primers were then extended by the addition of 20 p.l of a reverse transcriptase mixture containing 500 p.M each dATP, dGTP, dCTP, and TTP, 200 U of Moloney murine leukemia virus reverse transcriptase (Bethesda Research Laboratories), 0.1 M TrisHCl (pH 8.3), 0.15 M KCl, 6 mM MgCI2, and 20 mM dithiothreitol and incubation for 30 to 60 min at 45°C. The samples were then digested with RNase, extracted with phenol and chloroform, and analyzed on 6% polyacrylamide-7 M urea gels.
The oligonucleotides used for primer extension analysis of transcription products from the p19 and p40 promoters were each 20 nucleotides long. The p19 primer consisted of the AAV nucleotide sequence from 960 to 941, 5'-GCGCATCA GAATTGGGATTC-3', and yielded a primer extension product of 88 nucleotides. The p40 primer was from AAV nucleotides 1904 to 1885, 5'-GTCTGCGTAGTTGATCG AAG-3', and yielded a primer extension product of 52 nucleotides.
In vitro transcription and translation. Plasmid DNA (2 p.g) was digested with XhoI. Following phenol extraction and ethanol precipitation, the DNA was dissolved in 50 ,ul of a reaction mixture containing 40 mM Tris-HCI (pH 7.9), 6 mM MgCl2, 2 mM spermidine, 10 mM dithiothreitol, 0.5 mM each ATP, UTP, GTP, and CTP, 20 U of RNasin (Promega), and (32) .
The series of five contiguous 30-bp internal deletions upstream from the p19 and p40 promoters (Table 1) were constructed by oligonucleotide-directed mutagenesis (27) and have been described previously (32) . Although the Rep protein reading frame is maintained in these constructs, two of the deletions, d11700 and d11730, result in an additional amino acid change of Lys-460 to Asn and Phe-470 to Leu, respectively. The point mutations were made by the same protocols. Each of the oligonucleotides used to generate a point mutation was synthesized with the possibility of two different nucleotides at the position to be mutated. Thus, two possible amino acid substitutions were directed to each position. Each mutation was confirmed by DNA sequencing.
The Rep-plasmid d13-23 was derived from pSM620 (39) and has been described previously (20) . It contained both the left and right TRs and a functional capsid gene but was missing AAV nucleotides 144 to 1059, which span the two promoters for transcription of rep mRNA (p5 and p19) and most of the Rep protein-coding region.
RESULTS
We used oligonucleotide-directed mutagenesis to introduce a series of in-frame deletions and amino acid substitution mutations in the Rep coding region of AAV ( Table 1 ). All of these mutations were derived from the plasmid pIM29 ( Fig. 1) , which contained the entire protein-coding region of AAV but lacked the terminal sequences. When pIM29 was transfected into Ad2-infected HeLa cells, the three AAV promoters were induced to wild-type levels of transcription by the Rep protein expressed from the p5 promoter in a replication-independent manner (32) .
Activation of transcription in HeLa cells. Each of the pIM29-derived plasmids which contained an amino acid substitution mutation in the rep region was transfected into Ad2-infected HeLa cells. Total cellular RNA was harvested, and transcription from the AAV p19 and p40 promoters was assayed by primer extension ( Fig. 2 and Table 1 ). pIM29, which produces wild-type Rep, was used in parallel transfections as a standard for Rep-induced transcription. Only 3 of the 13 amino acid substitution mutants tested, P365T, P505H, and P505L, induced transcription from the p19 and p40 promoters. P365A, in contrast to P365T, did not transactivate. We did not rule out the possibility that the low level of p40 transcript observed in transfections with transactivation-defective Rep mutants results from a residual Rep activity.
The 10 deletion mutations were also tested by transfection into Ad2-infected HeLa cells. The transactivation phenotypes of these mutations, both in cis and in trans, have been VOL. 66, 1992 
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reported previously (32) and are summarized in Table 1 . Only the two C-terminal-most deletions, spanning amino acids 491 to 500 and 501 to 510 (d11790 and d11820, respectively), were positive for transactivation of the AAV p19 and Primer extension analysis of p40 transcripts showed that the three mutants (P365T, P505H, and P505L) which were able to activate the p40 and p19 promoters in the absence of the TRs (Fig. 2 ) also activated the p40 promoter of d13-23 (Fig.  3) . None of the other mutants were positive for transactivation of the d13-23 p40 promoter.
DNA replication phenotype. All of the mutant rep genes were tested for their ability to complement the Rep-Ori+ deletion mutant d13-23 for replication in vivo. Replication in Ad2-infected HeLa cells was assayed by filter hybridization of low-molecular-weight DNA from the cells cotransfected with d13-23 and the mutant (Fig. 4 and Table 1 ). In all cases, the mutants which were defective for transactivation were also defective for DNA replication. This suggested that a subset of Rep activities were essential for both DNA replication and transactivation of AAV promoters or, alternatively, that the mutant Rep proteins either were not being expressed or were not stable.
The expression of Rep78 and Rep68 in the experiments described above was controlled by the AAV p5 promoter of pIM29. This promoter is activated by the Ad2 Ela gene (7) and then induced to higher levels of transcription by the Rep protein (28) . In order to eliminate the possibility that the relationship between transactivation and replication was the result of limiting amounts of the Rep protein produced by the mutants which were negative for transactivation, the mutant proteins were expressed in an in vitro transcription-translation system and assayed independently for replication-associated activities in vitro. A T7 RNA polymerase promoter at the left end of the wt and mutant AAV inserts was used to generate transcripts, which were subsequently translated into protein by using rabbit reticulocyte extracts. Aliquots of the translation reaction mix were electrophoresed on sodium dodecyl sulfate-polyacrylamide gels, and a scanning gas flow counter (AMBIS) was used to normalize protein levels for the assays described below.
TR binding activity in vitro. The in vitro-synthesized Rep proteins were first assayed for their ability to recognize and bind to the AAV TR in its hairpin configuration as described previously (23, 25) . Wild-type Rep68 and Rep78 from AAVinfected HeLa cells bind avidly to this substrate, and the protein-DNA complex is easily detected by an electrophoretic mobility shift assay. AAV TR binding by in vitrotranslated, wild-type Rep68 was qualitatively similar to binding by Rep68 protein purified from AAV-infected HeLa cells (Fig. 5, left panel) . Binding with in vitro-translated Rep78 was identical to that with Rep68 (compare Fig. 5 and Fig. 6 ). Additionally, the 32P-labeled Rep68-DNA complex could be specifically inhibited with excess unlabeled AAV TR (data not shown). All of the mutants tested subsequently were synthesized in vitro from Rep78 mRNA.
When Rep protein translated from the 10 deletion mutants was tested in the TR binding assay, only the two deletions which were positive for replication and transactivation in vivo bound to the TR in vitro (Fig. 5 , right panel, d11790 and d11820; Table 1 ). These were the two C-terminal-most deletions, spanning amino acids 491 to 510. Their binding was indistinguishable from that of wild-type Rep78 (not shown; see Fig. 6 ). Binding was not detected with proteins synthesized from mutants bearing deletions between amino acids 461 and 490 (Fig. 5, d11700 to d11760) and amino acids 134 to 183 (Fig. 5, d1720 to d1840) . Thus, the replication-negative Table 1 for amino acid coordinates).
phenotype of these mutants derives, at least in part, from their inability to bind to the TRs, which are the viral origins of DNA replication. This does not, however, account for their failure to transactivate in the absence of the TRs.
In contrast to the deletion mutants, many of the point mutants which were negative for transactivation and replication in transfected cells were able to bind to the TR substrate in vitro (Fig. 6) . Binding was readily detected at wild-type levels for mutants with point mutations between amino acids 341 and 404, with the exception of mutants E379Q and E379K, which appeared to bind quantitatively less DNA than the wild-type protein. W242L was negative for binding and may contain a mutation in the same DNAbinding domain as was affected by the series of deletions between amino acids 134 and 183 (Fig. 5, d1720 to d1810) . P415H (not shown) also eliminated binding, suggesting that its mutation lay within the DNA-binding domain which was affected by the deletion mutations between amino acids 461 and 490 (d11700 to d11760). The mutations in TN341IY were directed to the threonine residue and the following asparigine at the amino-terminal end of the consensus purine nucleotide-binding site, GXXXXGKT, of the Rep protein. Figure 6 shows that this mutation does not affect TR binding in vitro. This is consistent with previous studies which have shown that ATP hydrolysis is required for terminal resolution by Rep but not for binding to the TR (8, 23, 25, 45) . Both P365A and P365T were positive for TR binding in vitro (Fig.  6 ). These mutants were negative and positive, respectively, for both replication and transactivation in vivo. Taken together, the results with the point mutations and deletions suggest that there are at least two regions of Rep protein which are essential for binding to the AAV TRs, one between amino acids 134 and 242 and the other between amino acids 415 and 490. The mutations in the region between the two DNA-binding domains which result in the loss of in vivo functions must affect a subsequent step in replication which also appears to be required for transactivation ( Fig. 1 and Table 1 ). trs endonuclease activities. The in vitro-synthesized mutant Rep proteins were also assayed for trs endonuclease activity. The substrate for these reactions was the same as that used in the binding reactions and, as above, was labeled at the 5' end. In the presence of Mg2" and ATP, trs-specific cleavage yields a labeled 73-nucleotide single-stranded DNA fragment as the product of the reaction. As expected, given the results of the previous assays, the two most C-terminal deletion mutants, which were positive for replication and transactivation in vivo and able to bind to the TR ( Fig. 2;  Fig. 4; Fig. 5 , d11790 and d11820; Table 1 ), were also positive for endonucleolytic cleavage at the trs (Fig. 7, top, d11790 and d11820). Four of the point mutants, P365A, P365T, P505H, and P505L (Fig. 7, bottom) , were able to cleave the AAV TR substrate. Of these four, only P365A was negative for replication and transactivation in vivo. P365A does, however, exhibit a significantly and reproducibly lower trs endonuclease activity than either P365T or wild-type protein. P505L, which apparently yielded a reduced trs endonuclease activity relative to the wild type in the assay shown in Fig. 7 , had wild-type levels of activity in two additional assays, while P365A trs endonuclease activity was consistently reduced (data not shown). Thus, each mutant which had been negative for both replication and transactivation showed a defect in its ability to promote the trs cleavage reaction. This suggested that there was an activity in addition to DNA binding that was essential for both transactivation and trs cleavage.
DISCUSSION
We have tested a series of point mutations and deletions in the Rep open reading frame both in vivo and in vitro. In transfected HeLa cells, we have found in each case that when a mutant is negative for DNA replication, it is also unable to transactivate the AAV promoters in either the presence or absence of the AAV TRs in cis. When the mutant proteins were expressed in vitro and assayed for TR binding and trs endonuclease activity, two mutant phenotypes were observed, proteins that did not bind to the TR and those that bound but did not cleave the trs. Mutants --~73 which were negative for either of these activities in vitro were also negative for replication and transactivation in vivo. With a single exception (P365A), the mutants which were positive for both of these activities in vitro were also positive for replication and transactivation in vivo. The relationships between TR binding, trs cleavage, and replication are evident, as TR binding is required for the latter two activities. trs cleavage is also intrinsic to the replication mechanism. In contrast, the relationship between these activities and the transactivation of AAV promoters in the absence of the terminal repeats is not obvious. While the TRs can substitute for promoter-associated cis-active elements in the transactivation of p40, they are not essential when the three AAV promoters are left intact (32) . One possible explanation is that the mutations leading to the TR-binding-negative and trs endonuclease-negative phenotypes are affecting an additional Rep activity, namely, its ATP-dependent DNA helicase, which could be directly involved in transactivation.
There are two noncontiguous regions of Rep which are essential for TR binding (Fig. 1) . One extends into the region unique to the two larger Rep proteins and maps between amino acids 134 and 242. The other, which is included in all four Rep proteins, spans amino acids 415 to 490. In addition to their TR-binding functions, the roles of these two regions may include the nonspecific DNA-binding activity which we must infer to be present in Rep by virtue of its ability to unwind duplex DNA independently of its sequence (24) . Thus, in the absence of the TRs in cis, the nonspecific DNA-binding activity of Rep might enable it to interact with the AAV promoters either directly or in cooperation with a sequence-specific transcription factor. We have not as yet been able to determine the nonspecific DNA-binding phenotypes of the in vitro-translated Rep proteins owing to the high level of DNA-binding activity present in the reticulocyte lysates.
The second aspect of these results which implicates the Rep helicase activity in transcriptional activation is the correlation between trs endonuclease activity and transactivation. Site-specific nicking at the trs, per se, probably has no bearing on transactivation. However, because the trs endonuclease reaction is ATP dependent, mutants which are negative for this activity may also reflect mutations in the ATPase region of Rep. Such mutants would also be expected to be defective for the ATP-dependent helicase activity. In support of the notion that our trs-negative mutants are defective in ATPase, we note first that the mutation in one of these mutants, TN341IY, had been specifically targeted to a consensus purine nucleotide-binding site in Rep protein.
TN341IY is negative for transactivation, replication, and trs endonuclease but positive for TR binding. This is consistent with previous observations that trs cleavage is dependent upon the hydrolysis of ATP, whereas TR binding is not (1, 23, 24) . The loss of transactivation in the TN341IY mutant suggests that ATP is required for Rep-induced activation of AAV transcription. A similar mutation of the lysine residue in the ATP-binding site of parvovirus H-1 NS1 protein (which is analogous to the AAV Rep protein and has extensive amino acid sequence similarity) also results in loss of transactivation (30) .
Additional support for a relationship between the trsnegative phenotype and ATPase activity is provided by mutations which fall within an extended ATPase region (Fig.  1) identified by analogy to polyomavirus T antigen. It has previously been shown that parvovirus Rep and NS proteins have limited sequence similarity with simian virus 40 T antigen (2) that is particularly strong within the 110-aminoacid ATPase region of T antigen (6) . With the exception of P365T, mutants carrying mutations within this region of the Rep protein (amino acids 326 to 419) are defective for both transactivation and replication in vivo and (with the further exception of P365A) trs endonuclease activity in vitro (Fig.  1) . P365T cleaves the trs site at the same level as wild-type Rep, and P365A is partially defective. The observation that the mutants carrying mutations within the putative ATPase region of the Rep protein are defective for both trs endonuclease activity and transactivation activity suggests that they have a requirement for an ATP-dependent enzymatic activity. This may reflect a requirement for the ATP-dependent DNA helicase activity of Rep protein. If the helicase activity is essential for induction of AAV transcription by Rep protein, it would represent a novel mechanism of promoterspecific transactivation. In contrast, although polyomavirus T antigen is also an ATP-dependent DNA helicase and a promoter-specific transactivator, its transcriptional activation functions are not ablated by mutations in the ATPase region (51) .
It is also possible that ATP is required for Rep-mediated transactivation through a mechanism which does not involve a helicase activity. There are several well-characterized examples of transcriptional activators that use ATP in prokaryotes. In Salmonella typhimurium, the hydrolysis of ATP is required for transcriptional activation by the phosphory-VOL. 66, 1992 lated form of the NtrC protein (49) . In contrast, the MalT regulatory protein of Escherichia coli, a weak ATPase, requires the binding but not hydrolysis of either ATP or a nonhydrolyzable analog of ATP as a prerequisite for interaction with its promoter-associated recognition sequences (38) . Additionally, the replication-dependent activation of phage T4 late-gene transcription requires the hydrolysis of ATP (19) . Eukaryotic general transcription factors also display various nucleoside triphosphate requirements. The initiation of transcription following assembly of the RNA polymerase II preinitiation complex requires the hydrolysis of ATP (42) . Nucleoside triphosphate binding but not hydrolysis is required for the formation of the 5S RNA gene polymerase III preinitiation complex (5) . The transactivation activity of hepatitis B virus Hbx protein is dependent upon the hydrolysis of ATP and appears to function via a protein serine/threonine kinase activity, which may modify cellular transcription factors (50) . Neither the Hbx protein nor the AAV Rep protein contains amino acid sequence motifs common to other known protein kinases (17) . If Rep protein does, indeed, require ATP for transactivation, a helicasedependent mechanism still seems the most plausible in light of its established ATP-dependent helicase activity.
Finally, we note that in a previous study of a lysine to histidine mutation in the rep consensus purine nucleotidebinding site, the mutant Rep protein was also found to be defective for replication and positive for TR binding (8, 36 (43) .
The possibility that Rep protein exerts its effects on replication, transactivation, and perhaps even translation through its helicase activity would explain many aspects of the multifunctional nature of this protein, the particular activity in each case being specified by the substrate. However, direct evidence for ATP dependence in any functions other than those related to DNA replication is still lacking. Further purification of the in vitro-translated Rep proteins should allow direct assays for helicase activity from the mutations in the TR-binding and ATPase regions. Direct evidence for either a DNA helicase activity or another ATP utilization requirement in transactivation will only be available with the development of an in vitro transcription system which reproduces the induction of transcription from AAV promoters by the Rep protein.
